IP Library Granted Patent US 10,888,620
Granted Patent B2
US 10,888,620 · App. 15/824,301 · Granted Jan 12, 2021

Liquid compositions for treating cough or cold symptoms

Inventors: Gerard P. McNally (Glenside, PA); Anurag Pandey (Lafayette Hill, PA); Vipul Dave (Hillsborough, NJ)
Assignee: Johnson & Johnson Consumer Inc.
A61K47/38A61K9/08A61K31/09A61K31/137A61K31/167A61K31/192A61K31/485A61K47/10A61K47/26A61K47/32A61K47/34A61P11/00A61P11/04A61P11/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,888,620
App. No.
15/824,301
Granted
Jan 12, 2021
Kind
B2
Abstract

Compositions useful in the treatment of cough and cold symptoms, including but not limited to, cough, nasal congestion and sore throat, are disclosed.

Claims (11)

1. A liquid composition for treating cough or cold symptoms, wherein said liquid composition comprises between about 0.1% and 3.0% of a mucoadhesive material, wherein said mucoadhesive material is a hydroxypropylmethylcellulose, and wherein said liquid composition further comprising from about 0.1% and 1.5% surfactant and wherein said surfactant comprises poloxamer 188, wherein said liquid composition has a traction coefficient of less than about 0.01 at 1-15 mm/sec rolling speed at 37° C., a slide to roll ratio (SRR) of 50% and 2 N normal load.

2. The liquid composition of claim 1 , further comprising an active ingredient.

3. The liquid composition of claim 2 , wherein the active ingredient is an analgesic.

4. The liquid composition of claim 2 , wherein the active ingredient is selected from the group consisting of acetaminophen, dextromethorphan, guaifenesin, ibuprofen and phenylepherine.

5. The liquid composition of claim 2 , wherein the active ingredient comprises acetaminophen.

6. The liquid composition of claim 1 , wherein the composition comprises a sensate.

7. The liquid composition of claim 1 , wherein said liquid composition further comprising a second mucoadhesive material.

8. The liquid composition of claim 7 , wherein the second mucoadhesive material comprises microcrystalline cellulose and sodium carboxymethyl cellulose.

9. A method of alleviating a symptom selected from the group consisting of cough, nasal congestion and sore throat in a subject comprising administering to a subject in need thereof the composition of claim 1 .

10. The method of claim 9 , wherein the symptom is sore throat.

11. The method of claim 9 , wherein said liquid composition has a traction coefficient of from about 0.001-0.010 at 1-15 mm/sec rolling speed when tested in accordance with the method disclosed herein.

Assignments (8)
CHANGE OF NAME Recorded Oct 28, 2024
From: JOHNSON & JOHNSON CONSUMER INC.
To: KENVUE BRANDS LLC
Reel/Frame 069267/0143 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2019
From: DAVE, VIPUL
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 051071/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: MCNALLY, GERARD P.; PANDEY, ANURAG
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 045596/0459 →
Continuity (2)
Provisional Application 62427080 · Nov 28, 2016
Related Publication 20180147285A1 · May 31, 2018